This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
News

Evaluating the effect of breast screening on mortality in England

Women who undergo screening for breast cancer at least once reduce their risk of breast cancer mortality by over a third, according to an article published in the British Journal of Cancer.

This England-wide study follows an initial pilot case-control study in London which indicated that attending mammography screening led to a mortality reduction of 39 per cent. Based on the same study protocol, an England-wide study was set up. Women aged 47-89 years who died of primary breast cancer in 2010 or 2011 were selected as cases (n=8288). Just over 15,200 control participants were matched by date of birth and screening area.

The latest data show a 37 per cent reduction in breast cancer mortality for women screened at least once, corresponding to approximately nine breast cancer deaths prevented between ages 55 and 79 for every 1000 women attending screening at ages 50-69 years.

The effect of screening within the NHS Breast Screening Programme in England was stronger and longer-lasting in women aged 65 years or over, but it remained highly relevant for younger women.

Corresponding author Professor Stephen Duffy from the Queen Mary University of London said: "The NHS Breast Screening Programme is doing its job in reducing the risk of death from breast cancer. Our results indicate that the benefit persists for 3-4 years in women aged under 65, so slippage of the three-year interval would be unsafe for these women.”


References


YOU MAY ALSO LIKE